Dr. Timothy R. Aksamit, MD

Dr. Aksamit practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Aksamit's NPI, 1184694770, was assigned on January 25, 2006. Dr. Aksamit graduated from Feinberg School of Medicine in 1985. Dr. Aksamit's Minnesota license number on file is 40532.

Dr. Aksamit's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Aksamit's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Aksamit to 3 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aksamit practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Aksamit's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Aksamit is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Aksamit's licenses on file in 3 states: Minnesota, Iowa and Wisconsin.

Dmand AI lists acute respiratory failure, asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis and pneumonia among the conditions Dr. Aksamit treats.

CMS data shows 1,478 Medicare services from Dr. Aksamit across 16 procedure codes in 2024, for 674 Medicare patients. Medicare paid $71,323 for them.

CMS counts 674 Medicare patients who saw Dr. Aksamit in 2024. The largest group is 65 to 74, with 348 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aksamit's median patient age at 68, with 55% women.

In 2024, Dr. Aksamit wrote 642 Medicare Part D claims for 125 patients. 73% of them were for generic drugs. CMS names the drug for 491 of them, across 17 drugs with 11 or more claims each, at $47,923 in total drug cost. In 2023, CMS named 628 claims across 20 drugs.

Dr. Aksamit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aksamit as offering telehealth.

Dmand AI links 102 papers to Dr. Aksamit, published from 2002 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Bronchiectasis, Mycobacterium Infections, Nontuberculous and Anti-Bacterial Agents. Dr. Aksamit has published most often in Chest. Dr. Aksamit's most frequent co-authors are Kevin Loring Winthrop, MD, Charles L. Daley, MD and David E. Griffith, MD.

Dmand AI links Dr. Aksamit to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Mycobacterium Infections, Nontuberculous, Mycobacterium avium-intracellulare Infection and Mycobacterium Infections.

CMS Open Payments shows 38 general payments to Dr. Aksamit from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 91% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $50,000.

Dmand AI lists 1 award for Dr. Aksamit, most recently ACP Fellow in 1997.

Dr. Aksamit graduated from Feinberg School of Medicine in 1985. Dr. Aksamit is a member of ACP.

Dr. Aksamit is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.